Physician profile
Charles Machell
NPI 1245230507
$4,460.53
in general payments reported to CMS, 2019-2025
15 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,595 · 2020: $824 · 2021: $520 · 2022: $405 · 2023: $526 · 2024: $316 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $911.85 | 2019-2020 | |
| Medtronic, INC. | $789.39 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Micra, Corevalve Evolut R |
| Medtronic Vascular, INC. | $743.33 | 2019-2020 | |
| Boston Scientific Corporation | $722.94 | 2019-2025 | Rhythmia Mapping System, Lux-Dx Insertable Cardiac Monitor, Versacross Access Solution |
| Biotronik INC. | $396.32 | 2019-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Biosense Webster, INC. | $346.19 | 2019-2022 | |
| Abbott Laboratories | $306.47 | 2019-2023 | Xience Sierra |
| Novartis Pharmaceuticals Corporation | $59.67 | 2019 | |
| W. L. Gore & Associates, INC. | $47.70 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Janssen Pharmaceuticals, INC | $43.52 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $38.70 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.40 | 2019 | |
| Cardiva Medical, INC. | $16.46 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Chiesi USA, INC. | $13.92 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.67 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Machell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.